Results 111 to 120 of about 554,110 (237)

Antiphospholipid antibodies and antiphospholipid syndrome [PDF]

open access: yes
Individuals with antiphospholipid syndrome (APS) have antibodies directed against phospholipid-binding proteins (aPL). The condition is most associated with an increased risk of thromboembolism and obstetric complications.
Hansen, Rasmus Søgaard   +4 more
core   +1 more source

Acute Cor Pulmonale Caused by Pulmonary Tumor Thrombotic Microangiopathy as the Initial Presentation of Multiple Myeloma: A Case Report

open access: yesPulmonary Circulation, Volume 16, Issue 4, October 2026.
ABSTRACT Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cause of acute cor pulmonale, typically associated with advanced solid tumors; its occurrence as the initial presentation of multiple myeloma (MM) has not been described. A 45‐year‐old woman developed acute right heart failure on postoperative day 1 after uterine myomectomy ...
Jianwei Cui, Bingzhen Zhao, Xin Ding
wiley   +1 more source

Frequency of antiphospholipid antibodies and antiphospholipid syndrome in women with recurrent miscarriages [PDF]

open access: yes, 1970
Summary Objectives: The aim of the study was to evaluate antiphospholipid antibodies and antiphospholipid syndrome frequency (according to current criteria) in women with recurrent miscarriages.
Skrzypczak, Jana, Rajewski, Marcin
core  

Intima‐Media Thickness Progression Rate and Primary Unassisted Patency Failure in Arteriovenous Fistulas: A Prospective Cohort Study

open access: yesHemodialysis International, Volume 30, Issue 4, Page 730-738, October 2026.
ABSTRACT Background Failure of autogenous arteriovenous fistulas (AV fistulas) due to venous neointimal hyperplasia is a major clinical challenge. Whether the rate of progression in venous intima‐media thickness predicts primary unassisted patency failure remains unknown.
Gen Li, Zhengjiang Cao
wiley   +1 more source

Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment

open access: yes, 2019
Antiphospholipid antibodies; B-cells; Belimumab; Hydroxychloroquine ...
Palterer, Boaz   +6 more
core   +1 more source

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli   +4 more
wiley   +1 more source

Diagnosis of antiphospholipid syndrome

open access: yes, 2008
Antiphospholipid syndrome is a multisystem autoimmune disease, characterized by recurrent vascular thrombosis and/or pregnancy losses in the presence of persistently positive antiphospholipid antibodies.
Khamashta, Munther A   +1 more
core   +1 more source

Thrombomodulin Shapes Thrombo‐Inflammatory Interactions in Lupus Nephritis

open access: yesScandinavian Journal of Immunology, Volume 104, Issue 4, October 2026.
Lupus nephritis is characterized by a distinct thrombo‐inflammatory profile dominated by endothelial activation, with thrombomodulin emerging as the most consistent biological marker of renal involvement in systemic lupus erythematosus. ABSTRACT Lupus nephritis (LN) confers a disproportionate thrombotic risk in systemic lupus erythematosus (SLE) that ...
Mads Lamm Larsen   +11 more
wiley   +1 more source

Anti-high density lipoproteins antibodies as novel biomarker for arterial events in thrombotic antiphospholipid syndrome patients

open access: yes, 2019
International Congress on Antiphospholipid Antibodies (ICAPA) (16th ...
Radin, Massimo   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy